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Abstract
Objectives: Rigid image registration (RIR) and deformable image registration (DIR)
are widely used in radiotherapy. This project aims to capture current international
approaches to image registration.
Methods: A survey was designed to identify variations in use, resources, implemen-
tation, and decision‐making criteria for clinical image registration. This was dis-
tributed to radiotherapy centers internationally in 2018.
Results: There were 57 responses internationally, from the Americas (46%), Aus-
tralia/New Zealand (32%), Europe (12%), and Asia (10%). Rigid image registration
and DIR were used clinically for computed tomography (CT)‐CT registration (96%
and 51%, respectively), followed by CT‐PET (81% and 47%), CT‐CBCT (84% and
19%), CT‐MR (93% and 19%), MR‐MR (49% and 5%), and CT‐US (9% and 0%).
Respondent centers performed DIR using dedicated software (75%) and treatment
planning systems (29%), with 84% having some form of DIR software. Centers have
clinically implemented DIR for atlas‐based segmentation (47%), multi‐modality treat-
ment planning (65%), and dose deformation (63%). The clinical use of DIR for multi‐
modality treatment planning and accounting for retreatments was considered to
have the highest benefit‐to‐risk ratio (69% and 67%, respectively).
Conclusions: This survey data provides useful insights on where, when, and how
image registration has been implemented in radiotherapy centers around the world.
DIR is mainly in clinical use for CT‐CT (51%) and CT‐PET (47%) for the head and
neck (43–57% over all use cases) region. The highest benefit‐risk ratio for clinical
use of DIR was for multi‐modality treatment planning and accounting for retreat-
ments, which also had higher clinical use than for adaptive radiotherapy and atlas‐
based segmentation.
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1 | INTRODUCTION
Medical image registration (IR) enables a user to combine and com-
pare information from multiple images and has applications in radiol-
ogy,1 nuclear medicine,2,3 and radiotherapy.4‐7 The use of images is
increasing in healthcare,1 and applications of IR can benefit patients
in diagnosis, planning, treatment, and response assessment.1 Almost
every software system that uses images in radiotherapy has rigid
image registration (RIR) functionalities4 that involves translational
and rotational corrections with up to 6 degrees of freedom. More
complex is deformable image registration (DIR) which has 3 degrees
of freedom for every voxel in the image.4 Validation and clinical
translation of IR have been considered challenging for over 20 yr,8
with DIR validation considered an unresolved subject.5,6
The report of the AAPM Radiation Therapy Committee Task
Group No. 1324 (TG 132) provides formal quality assurance guideli-
nes for IR. This report increased awareness in the need for formal
quality management to better understand, communicate, and manage
the uncertainty of both rigid and deformable image registration.
Accuracy in IR has direct and indirect implications for clinical risk,
such as interpretation of PTV.9 Rigid image registration is a well‐
established but limited technique when the size, shape, or the orien-
tation of structure is different between the two scans. DIR can
achieve superior spatial congruence between image pairs in certain
conditions (such as high contrast regions), but can be considered ill‐
defined and over‐constrained.4 As a single IR technique (RIR or DIR)
may not be robust for all circumstances,10 there is value in data to
help select an appropriate IR technique, and data to help decide on a
per‐patient IR quality assurance.4
With image‐guided radiotherapy (IGRT) surveys emphasizing the
growing importance of imaging,11‐14 there is also DIR adoption
data14‐16 that highlights the increase in complex IRs. Commercial
solutions and clinical needs are factors driving DIR use despite pub-
lished limitations and risks, resulting in a need to better understand
when, what, who, and how IR are clinically used. The aim of the sur-
vey was thus to measure useful reference data for the development
of productive implementation and quality assurance strategies
adapted toward clinical resources and requirements.
2 | MATERIALS AND METHODS
2.A | Question generation and review
The survey was created with Google Forms (Google LLC, California,
US) and was exploratory in nature. The survey was not endorsed in
an official capacity and it was not anticipated that all centers would
respond. Survey questions were designed to assess significant varia-
tions in the status of implementation and clinical use of IR, concen-
trating not only on DIR but also targeting RIR.
There were two versions of the survey, both in English: (a) for
radiotherapy centers in Australia/New Zealand (ANZ), and (b) for
international radiotherapy centers. Differences in the surveys were
that (a) ANZ respondents were questioned on which state/territory
they were within, and (b) wording was changed because Dosimetrists
as a staff speciality was not applicable in ANZ as Radiation Thera-
pists (RTs) perform both treatment and treatment planning roles.
Each department was requested to provide a single response from a
multidisciplinary team of Medical Physicists, RTs, Dosimetrists, and
Radiation Oncologists (ROs). There were 27 standard survey ques-
tions on core IR practice patterns, with expected completion within
10 min. There were 54 extended survey questions that focused on
DIR implementation with an additional 30 min required
(Appendix S1).
Standard survey questions included
i department characteristics
ii RIR/DIR utilization by image modality pair
iii DIR software utilized
iv first planned or actual adoption of DIR for each use case
v use of IR request and report forms
vi IR QA mechanisms
vii IR training
viii IR involvement by staff discipline
ix IR challenges
x IR uncertainties.
Extended survey questions included
i ideal levels of staff involvement in DIR
ii RIR/DIR applications by anatomical site
iii process‐based evaluation of responsibilities
iv process‐based evaluation of satisfaction levels
v metrics used for IR QA
vi validation datasets used
vii number of datasets by application
viii patient specific QA by application
ix IR techniques
x criteria for clinical release of IR
xi benefit‐to‐risk for IR
xii quality measures for safe use of RIR/DIR.
Table 9 contains the list of processes (xiii, xiv).
2.B | Survey data collection and analysis
On the April 19, 2018, the ANZ survey was distributed through
emails to Medical Physics Directors, while the INTL survey was dis-
tributed through the MEDPHYS email list hosted by Wayne State
University.16 Additional survey responses were obtained by emailing
AFOMP (Asia‐Oceania Federation of Organizations for Medical Phy-
sics) representatives from each region in Asia. The deadline was
extended on the August 24, 2018 and closed on the September 1,
2018. Survey data were exported from Google FormsTM (Google
LLC, California, US) into Microsoft ExcelTM (Microsoft Corporation,
Washington, US) for descriptive data analysis.
The data in the spreadsheet were anonymized. Search functions
were used in Microsoft ExcelTM to parse responses into number
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values, including accounting for not applicable (NA) or unsure
responses as nonresponses. An assessment was made of whether
exclusion of particular survey data should be considered, based on
issues found in areas including survey design, question type, or
respondent data.
3 | RESULTS
3.A | Inclusion and exclusion of data and analysis
In the standard survey, data from Asia (n = 6) on reported DIR soft-
ware (iii) were excluded due to insufficient data. Data on IR quality
assurance mechanisms (vi) were excluded due to high rates of “none
of the above,” with 35% for Americas (AMS), 50% for Asia 50%,
43% for Europe (EU), and 6% for ANZ (Table 10). In the extended
survey, results on the number of datasets (xvi), the number of data-
sets used for commissioning by application (xvii), and patient‐specific
QA (xviii) were excluded as there was no ability for respondents to
skip questions that were not applicable to them and they were
forced to input nominal values to questions.
3.B | Respondent data
From the standard survey, 57 departments responded interna-
tionally [Fig. 1(a)] with data from each geographical region were
analyzed. The extended survey had 23 international responses
[Fig. 1(b)]: data from AMS (n = 8) and ANZ (n = 12) were ana-
lyzed but data from Asia (n = 2) and EU (n = 1) were not
included in analysis at all due to very limited responses. Multi‐
site and single‐site departments were registered as a single
response. Fifty‐four percent of departments operated as a single
site (AMS 38%, Asia 67%, EU 71%, ANZ 67%) and 60% were
public sector departments (AMS 46%, Asia 67%, EU 86%, ANZ
67%). Departments had an average of five treatment units
(range 1–24) over all treatment modalities (such as megavoltage
and kilovoltage external beam therapy units, or brachytherapy
machines).
3.B.1 | Department responsibilities
Internationally, respondents noted their responsibilities with external
beam radiotherapy (98%), 65% with brachytherapy, 21% with
nuclear medicine, and 21% with radiology (see Fig. 2). Departments
were also surveyed on university affiliation (international rate of
30%).
3.B.2 | Standalone DIR and RTPS DIR software
The combined international results on centers’ exposure to systems
with DIR are presented in Table 1 (indirectly indicating clinical and/
or research use). In 2018, dedicated DIR software was the most
common (AMS 88%, EU 71%, ANZ 50%), followed by DIR‐enabled
RTPS (AMS 12%, EU 43%, ANZ 33%), with some indications of
multiple types of dedicated DIR software (AMS 12%, EU 29%,
ANZ 28%). The least common pattern was a combination of dedi-
cated DIR software with DIR‐enabled RTPS (AMS 4%, EU 14%,
ANZ 11%). Use of DIR validation software was 12% internationally
(AMS 8%, EU 29%, ANZ 11%) and 8% for open source DIR soft-
ware (AMS 4%, EU 0%, ANZ 11%). The majority of departments
reported exposure to some form of clinical DIR software (either
dedicated DIR software or RTPS with DIR) in 2018 (AMS 92%, EU
71%, ANZ 61 %).
In 2018, data indicate that MIMTM (MIM Software Inc., Cleve-
land, US) was prevalent internationally (43%), in AMS (54%), and
ANZ (44%) but not in EU (0%). VelocityTM (Varian Medical Sys-
tems Inc., CA, US) had international usage of 41% spread over
F I G . 1 . Standard survey (Left) with 26 responses from Americas,
18 from ANZ, 7 from EU, and 6 from Asia. Extended survey (Right)
with 8 from Americas and 12 from ANZ; 1 response from EU and 2
from Asia were excluded from analysis (striped pattern). The color
coding used (online version) involves ANZ blue, AMS red, Asia
green, and Europe gray.
F I G . 2 . Department responsibilities for external beam
radiotherapy, brachytherapy, nuclear medicine, and radiology by
region.
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AMS (46%), EU (43%), and ANZ (39%). MiradaTM (Mirada Medical,
Oxford, UK) had international usage of 8%, with most centers in
EU (29%), some in ANZ (11%), and none in AMS. Internationally,
2% used ProsomaTM (Oncology Systems Limited, Shrewsbury, UK)
with 14% use in the EU. Among DIR‐enabled radiotherapy treat-
ment planning systems (RTPS), Pinnacle3 Treatment Planning Sys-
tem with DIR (Philips, Amsterdam, Netherlands) had 12% INTL
usage in 2018, with AMS (8%), EU (29%), and ANZ (11%). Raysta-
tion® with DIR (Raysearch Laboratories, Stockholm, Sweden) also
had 12% of INTL use in 2018, with 12% in AMS, 17% in ANZ,
but no uptake in EU. EclipseTM with DIR (Varian Medical Systems
Inc., CA, US) had use of 7%, BRAINLABTM with DIR (Brainlab AG,
Munich, Germany) 4%, and MRIdian® (ViewRay, Ohio, US) with
DIR 2% internationally.
For dedicated DIR verification software, ImSimQATM (Oncology
Systems Limited, Shrewsbury, UK) had 12% INTL in 2018, with
8% in AMS, 29% in EU, and 11% in ANZ. In 2018, there was a
usage of open source DIR software of 8% internationally, with 4%
in AMS, 17% in ANZ, and none in the EU. Among these, there
was usage of Plastimatch17 of 5%, ITK18 4%, Slicer19 4%, and DIR-
ART20 at 2%.
3.C | Clinical adoption of rigid and deformable
image registration
3.C.1 | Cumulative adoption of image registration
techniques
Cumulative adoption curves indicate that the practice pattern for
DIR is differentiated between use for atlas‐based segmentation, dose
operations, and multi‐modality treatment planning (see Fig. 3). Adop-
tion of DIR for dose (circle) and multi‐modality treatment planning
(crosses) generally increased together, with a different pattern of
atlas‐based segmentation (lines) uptake. Open text responses on
adoption of DIR by IR technique are presented in Appendix S2.
3.C.2 | Uptake of RIR and DIR by image modality
pair
Internationally, almost all respondents utilized CT‐CT with RIR (96%)
with substantial use of DIR (51%). As RIR is an initialization step for
DIR or could be used on its own, all RIR use values were higher than
DIR. Ninety‐three percent used CT‐MR with RIR and 19% using DIR.
Eighty‐one percent used RIR for CT‐PET with 47% using DIR. This
data is nonspecific as to whether a planning CT is registered to the
PET or the diagnostic CT. It is noted that a typical DIR process
involves a DIR between the pCT and the dCT, with a further chain
registration that utilizes a RIR of the dCT to the PET to display the
pCT to the PET (similarly for SPECT). Eighty‐four percent used RIR
for CT‐CBCT with 19% using DIR. Forty‐nine percent used RIR for
MR‐MR with 5% using DIR. Nine percent used RIR for CT‐US with
no respondent use of DIR for that combination (see Table 2).
3.C.3 | Uptake of DIR by anatomical site
International data (AMS n = 8 and ANZ n = 12) on the uptake of
DIR over anatomical sites are presented in Table 3. In AMS, DIR was
most heavily used for head and neck, with 50% RIR vs 63% DIR for
adaptive radiotherapy (ART), 100% RIR vs 88% DIR for multi‐modal-
ity treatment planning (MMTP), and 88% for both RIR and DIR when
accounting for previous dose. Lung was the second site with most
DIR use (50% ART, 63% MMTP, and 63% accounting for previous
dose). Even with high DIR use in the head and neck and lung, the
brain was a site where RIR dominated DIR use (13% vs 0% for ART,
88% vs 50% for MMTP, 75% vs 25% to account for previous dose).
The pelvis, considered in this study to be a broad category for the
pelvic region for both genders that also includes the prostate, repre-
sented a site where RIR dominated DIR use (13% vs 0% for ART,
100% vs 38% for MMTP, 88% vs 50% to account for previous
dose).
The brain had the lowest levels of user‐reported ratings of uncer-
tainty (AMS 26%, ANZ 22%). Other sites had increased levels of
uncertainty: head and neck (AMS 63%, ANZ 42%), prostate (AMS
51%, ANZ 46%), breast (AMS 63%, ANZ 36%), esophagus (AMS
66%, ANZ 42%), pelvis (AMS 57%, ANZ 48%), and upper GI (AMS
TAB L E 1 International data of centers having exposure to systems
with dedicated DIR software (SW), radiotherapy treatment planning
system (RTPS) with DIR, and other DIR systems available in
departments (%), with (o) denoting responses from open text.









Dedicated DIR SW Velocity 14 41 45
MIM 22 43 45
Mirada 6 8 8
Prosoma (o) 2
MRIdian (o) 2
RTPS with DIR Pinnacle 8 12 16
Raystation 6 12 16
Eclipse (o) 8
Brainlab (o) 4






DIR validation SW ImSimQA 4 12 12
Any open source DIR SW All SW 8
Both dedicated DIR and
RTPS with DIR
All SW 8 16 20
Multiple dedicated DIR SW All SW 6 20 20
Any RTPS with DIR All SW 12 24 29
Any dedicated DIR SW All SW 33 73 75
Either dedicated DIR or
RTPS with DIR
All SW 49 80 84
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74%, ANZ 44%). Nonresponse rates for uncertainty (respondents
unsure) was on average 20% across anatomical sites, and was high-
est for hematological (AMS 63%, ANZ 25%) and sarcoma (AMS 50%,
ANZ 25%).
3.C.4 | Staff involvement in rigid and deformable
image registration
The extended survey captured respondents’ opinions on “ideal staff
numbers for DIR” if the department had sufficient time and
resources to train all staff (see Table 4). International practice varied
with AMS featuring the highest levels of Physicist involvement, and
ANZ the highest levels of RT involvement (AMS 30%, Asia 17%, EU
44%, ANZ 76%). Dosimetrists had higher levels of RIR involvement
than Physicists in AMS (AMS 66%, Asia 17%, EU 33%) but lower in
DIR than Physicists (AMS 51%, Asia 17%, EU 33%). RO involvement
in RIR (AMS 33%, Asia 60%, EU 16%, ANZ 66%) was higher than
DIR levels (AMS 28%, Asia 33%, EU 10%, ANZ 19%) with a large dif-
ference relative to ideal DIR involvement (AMS 55%, ANZ 77%). A
gap between existing and ideal levels of DIR involvement existed for
all staff groups, with gaps in ANZ larger than AMS for Physicists
(ANZ gap 53% vs. AMS gap 16%) and RTs (ANZ gap 62% vs. AMS
gap 10%).
3.D | Implementation and operational
characteristics
3.D.1 | Image registration training
Training data are presented in Table 5. Internationally, formal train-
ing regimens were uncommon for IR (INTL 7% for RO, 11% for RTs,
12% for RO, and no data on Dosimetrists). Anatomical site‐specific
training was low (INTL 12%). Self‐training with standard operating
procedures (INTL 33%), online materials (INTL 33%), and vendor
material (47%) were used in conjunction with informal peer training
(INTL 70%) and self‐assessment of competency (65%). Vendor‐based
training was common (INTL 67%).
3.D.2 | Image registration processes evaluation
The extended survey captured process performance by relative satis-
faction and number of staff group involvement (see Fig. 4). Average
number of staff group involvement for upstream processes (AMS
1.8, ANZ 1.7) and registration processes (AMS 1.4, ANZ 1.4) were
higher than downstream (AMS 1.2, ANZ 0.8). Averaged relative
F I G . 3 . Cumulative adoption of atlas‐
based segmentation (Atlas), deformable
image registration with dose (DIR_Dose),
and multi‐modality treatment planning
(DIR_MMTP); note that data for 2018 and
onward are indicative of respondent
intentions and not actual adoption. Results
are divided with color coding (online
version) with ANZ blue, AMS red, Asia
green, and Europe gray
TAB L E 2 Utilization of rigid image registration (RIR) and deformable
image registration (DIR) by image modality pair (%).
Americas Asia EU ANZ INTL
CT‐CT
RIR 92 100 100 100 96
DIR 77 33 43 22 51
CT‐MR
RIR 92 83 86 100 93
DIR 27 33 29 0 19
CT‐PET
RIR 73 83 71 94 81
DIR 77 50 0 22 47
CT‐CBCT
RIR 85 83 100 78 84
DIR 15 33 43 11 19
CT‐US
RIR 8 17 0 11 9
DIR 0 0 0 0 0
MR‐MR
RIR 46 33 57 56 49
DIR 4 17 14 0 5
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satisfaction of processes for upstream processes (AMS 1.2, ANZ 1.5)
and registration processes (AMS 1.1, ANZ 1.4) were similarly higher
than downstream processes (AMS 1.0, ANZ 1.4). For management
processes, relative average satisfaction was similar in AMS and ANZ
(AMS 1.2, ANZ 1.3) while staff group involvement varied (AMS 1.0,
ANZ 1.7). The lowest level of staff group involvement in AMS was
in‐house software engineering (0.5); in ANZ, it was for checking of
atlas‐based segmentation (0.3) and the process to validate deformed
image and dose (0.6). The lowest level of relative satisfaction in
AMS was for explicit registration prescription and documentation of
uncertainties (0.8 each); for ANZ, the lowest satisfaction was with
processes in decision when registrations had risk of deformation
(TG132 registration accuracy4 level 2), with a score of 1.1. Average
rates of N/A responses for registration (AMS 2%, ANZ 15%) and
downstream (AMS 5%, ANZ 41%) were higher than for upstream
(1% each) or management (AMS 14%, ANZ 8%). Processes with
TAB L E 3 International data by anatomical site on the use of rigid (RIR) and deformable image registration (DIR) for multi‐modality treatment
planning (MMTP), accounting for previous treatment (Prev Tx eval), adaptive radiotherapy (ART), and atlas‐based segmentation (%). Ratings of
uncertainty of DIR with images and dose are in the last column (higher value represents more uncertainty, scaled from 0 to 100%).
MMTP Prev Tx eval ART
Atlas‐based Uncertainty
RIR DIR RIR DIR RIR DIR segmentation DIR
Brain 96 30 83 26 48 17 43 24
Head and neck 100 57 87 57 65 43 43 51
Breast 52 22 70 30 35 17 22 46
Lung 100 43 87 39 52 35 26 55
Esophagus 87 43 87 35 43 17 17 52
Pelvis 96 30 83 30 52 17 26 52
Prostate 96 30 87 35 48 22 30 48
Upper GI 83 30 83 30 39 17 17 56
Sarcoma 65 26 61 13 39 17 13 34
Hematological 39 13 48 13 26 9 9 25
TAB L E 4 Staff involvement across geographical continents for rigid
image registration (RIR) and deformable image registration (DIR) at
current levels based on standard survey (n = 57); data on ideal levels
were based on extended survey (n = 23) which had limited data
from Asia and EU. Note that NA indicates lack of extended survey
data of ideal levels of DIR staff involvement. Note that Dosimetrist
is not applicable for ANZ, and is omitted from the table.
RIR current DIR current DIR ideal
Radiation Oncologist
ANZ 66 19 77
AMS 33 28 55
ASIA 60 33 NA
EU 16 10 NA
Medical Physicist
ANZ 38 23 77
AMS 56 57 73
ASIA 50 27 NA
EU 47 39 NA
Radiation Therapist
ANZ 76 21 83
AMS 30 12 23
ASIA 17 13 NA
EU 44 13 NA
Dosimetrist
AMS 66 51 80
ASIA 30 17 NA
EU 44 33 NA
TAB L E 5 Data from image registration training question.
Respondent responses (%) per conti-
nent Americas Asia EU ANZ
Self‐training with vendor material 65 33 29 33
Self‐training with online material 46 33 0 28
Self‐training with standard operating
procedures
27 33 29 44
Informal peer training 58 33 71 100
Vendor training 85 33 29 67
Competency based assessment — self
assessed
73 50 57 61
Competency based assessment —
trainer assessed
0 0 14 33
Competency based assessment —
written exam
0 0 0 0
Competency based assessment —
practical exam
0 0 0 0
Clinical training guide for trainees 0 0 0 6
Training program for RO 0 33 0 11
Training program for RT 0 0 14 33
Training program for Physicist 8 17 14 11
Anatomical site specific training 0 17 14 28
No formal training program 15 33 0 0
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highest N/A in AMS for in‐house software engineering (50%) and for
ANZ were with the process to validate deformed doses and images
(67%).
3.D.3 | Image registration challenges
The standard survey captured key challenges of respondents by con-
tinent (see Table 6). Internationally, 38% respondents reported chal-
lenges in upstream processes, 44% for registration challenges, 39%
for downstream challenges, and 16% for management challenges.
For upstream processes, reported challenges were 47% for image
quality, 39% for cropped images, 37% for communications on
intended use and registration technique, 30% on image selection,
and 28% on registration landmark required. For registration pro-
cesses, reported challenges were 47% on determining when registra-
tion was satisfactory, 46% on quantitative QA for DIR, and 39% on
qualitative QA for DIR. For downstream processes, reported chal-
lenges were 44% on actions for unsatisfactory registrations; with 33%
for documentation and/or appropriate follow up of registrations. For
management processes, reported challenges were 26% for image
transfer across multiple systems, 18% for image infrastructure (archive,
backup, etc.), 18% for image/software accessibility, 14% for defini-
tion of roles, and 7% for in‐house software engineering.
3.D.4 | Evaluation of image registration methods
The extended survey captured how nonstandard IRs are performed,
and how they would be performed based on respondent plans (see
Fig. 5). Internationally, there was (as of 2018) 74% respondents per-
forming multiple RIR at different local region(s), with plans for this to
reach 84% in the future. In terms of more advanced DIR, iterative
DIR techniques were the most common (current 36%, future 52%),
followed by use of contours/points to guide DIR (current 31%, future
47%), as well as contour masking to guide DIR (current 21%, future
37%). In terms of related DIR functions, dose propagation with DIR
(current 31%, future 58%) was more common than using DIR for HU
overrides such as generation of synthetic CT from CBCT (currently
15%, future 37%). Ancillary tasks including dose operations, such of
dose to account for incomplete delivery of radiotherapy fractions
was relatively common (current 41%, future 67%). In terms of quality
assurance, annotations to document regions of registration accuracy
(or lack of) were uncommon (current 26%, future 42%). Big data pro-
jects reliant on registrations (RIR or DIR) were uncommon (current
10%, future 37%).
3.D.5 | Evaluation of image registration quality
assurance metrics
The extended survey captured IR assessment methods and met-
rics, stratified by staff and by continent (See Table 7). This indi-
cates that qualitative assessment is more common than
quantitative assessments for each region (AMS vs ANZ) and for
all staff groups (RO, RT, Physicist, Dosimetrists). All staff groups
utilized qualitative assessment; the most common forms being
visual evaluation (INTL 66%, AMS 56%, ANZ 72%), comparison
with contours (INTL 51%, AMS 44%, ANZ 56%), and subjective
considerations (NTL 55%, AMS 53%, ANZ 56%); less common
were use of rulers/grids (INTL 35%, AMS 25%, ANZ 42%) or
screenshots (INTL 23%, AMS 13%, ANZ 31%). There were staff
and regional variation in the use of quantitative methods, primarily
by physicists (AMS 15%, ANZ 22%) but also with dosimetrists
(AMS 13%), therapists (AMS 0%, ANZ 10%), and RO (AMS 0%,
ANZ 7%). The most common quantitative metrics were target reg-
istration error and mean distance to agreement (INTL 14% each),
followed by dice similarity coefficient (INTL 11%), Jacobian (INTL
8%), and consistency (INTL 7%).
F I G . 4 . Evaluation of image registration
process by relative measures of
satisfaction (below 1 deemed
unsatisfactory — left side) and staff
involvement (below 1 on average having
some processes without staff involvement
— right side); processes grouped by (i)
upstream (1–9), (ii) registration (10–17), (iii)
downstream (18–25), and (iv) management
(26–32).
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3.D.6 | Image registration validation datasets
Internationally (AMS and ANZ), the extended survey captured data
on the types of validation datasets used (see Table 8), by image
modality and by subcategory of dataset types (clinical, physical, and
digital). The most common validation datasets by image modality
were for CT (38% averaged over all dataset types), CBCT (28%), MR
(23%), PET (18%), 4DCT (18%), 4DCBCT (16%), and the least com-
mon was US (9%). For digital datasets, there were similar rates of
deformable (15% averaged over all image modalities) and rigid (14%);
while for physical datasets, rigid datasets (34%) were more common
than deformable physical phantoms (6%), which had the lowest value
among all dataset types. For clinical datasets, retrospective (39%)
was more common than prospective (21%) data (Tables 9–11).
3.D.7 | Image registration request and report form
Figure 6 shows the level of awareness of the TG132 report with the
specific adoption of the IR request and report form. As of the survey
start (April 19, 2018) and the TG 132 report publication (May 23,
2017), international awareness of the report was common (INTL
82%) in all continents (AMS 83%, Asia 67%, EU 86%, ANZ 94%).
However, adoption of most recommendations for the IR request and
report form was not common (INTL 18%), with only Australasia hav-
ing a relatively high adoption rate (AMS 13%, Asia 0%, EU 14%,
ANZ 47%).
3.E | Quality, safety, and value in the
implementation of image registration
3.E.1 | Criteria for commissioning and implementing
image registration
Respondents were queried about what considerations they took into
account in the commissioning and implementation of DIR, and chose
the three most important criteria from a list.
Survey results (n = 20, AMS = 8, ANZ = 12) indicated that the
most commonly nominated criterion was a quality system to enable
measurement and improvement (overall 55%, AMS 75%, ANZ 42%).
The next most commonly nominated considerations were: effective
optimization of registration quality and QA (overall 45%, AMS 25%,
TAB L E 6 Survey data on key challenges for rigid and deformable
image registration (DIR).
Respondent responses (%) per conti-
nent Americas Asia EU ANZ
Image quality issues (resolution,
contrast, etc.)
42 50 71 44
Determining when registration
satisfactory
50 50 43 44
DIR Quantitative QA of ensuring
deformation is OK
58 17 43 39
Determining action when registration
unsatisfactory
50 50 14 44
Image cropped (scan length, field of
view, etc.)
35 33 57 39
DIR Qualitative QA of ensuring
deformation is OK
46 17 43 33
Communication on intended use and
technique
35 33 43 39
Documentation of registration accuracy
and follow‐up
35 33 14 39
Selecting the appropriate image 31 17 14 39
Insufficient training, trained staff
availability
23 33 14 44
Determining which registration
landmark required
35 33 14 22
Image transfer (import/export) of
multiple systems
15 33 29 39
Image infrastructure (storage, backup,
etc.)
12 0 14 33
Image or software accessibility 12 0 29 28
Insufficient definition of roles 12 33 14 11
In‐house software engineering 4 0 0 17
F I G . 5 . Evaluation of variation in
nonstandard image registration operations,
both currently used (2018) and planned for
the future; BED refers to biologically
effective dose.
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ANZ 58%); rapid efficient progress and clinical release (overall 45%,
AMS 25%, ANZ 58%); documentation and management of uncertain-
ties/risks (overall 45%, AMS 50%, ANZ 42); feasibility for tasks to be
practical and achievable (35%); roles and training to be specified and
managed (25%); ongoing and recurrent human and financial costs
(20%); compliance and best practice (10%); documentation of regis-
tration quality and error handling (10%); and proactive system valida-
tion and risk management (5%).
3.E.2 | Measures of quality and safety for image
registration
Open responses on the measures of quality for RIR were: (i) risk/inci-
dent entries, (ii) physical, (iii) digital or phantom measurements, (iv)
patient‐specific QA, (v) treatment outcomes based on toxicity, (vi)
qualitative IR checks, (vii) quantitative IR checks, (viii) peer review,
and (ix) user feedback. The responses for DIR added details including
(x) specific QA check on DIR by physics and RO, (xi) department
quality improvement system, (xii) that it depended on application, (xiii)
that application of best practice such as TG132 report, (xix) staff
confidence, (xx) audit results, and (xxi) specific pathways for tracking
DIR. Open responses on measures for ensuring safety of RIR and
DIR (e.g., how would incidents be detected) had similar responses,
but also included (xxii) audits and (xxiii) offline image reviews, and
(xxiv) having specifically trained staff QA DIR. General comments on
the quality and safety of DIR noted the (a) large learning curve for
DIR, (b) that DIR is high risk due as it is difficult to evaluate even for
experts as well (c) having dangerous consequences, (d) that a conser-
vative and cautious approach is required for deforming dose, (e) that
there are limits in current DIR algorithms, and (f) that suitable con-
trols with stop/go charts need to be implemented in clinical practice
to minimize risk.
3.E.3 | Evaluation of value in implementation of
DIR with risk‐benefit rating by use case
The International data (n = 20, AMS = 8, ANZ = 20) shown in Fig. 7
indicate that based on averaged values, the DIR functionality with
most value were for multi‐modality treatment planning (INTL 69%,
AMS 53%, ANZ 83%); followed by accounting for previous treat-
ment and response assessment (INTL 67%, AMS 56%, ANZ 75%).
The value of DIR for adaptive radiotherapy (defined as any use of
DIR for ART, without specifying processes) was nominated at 57%
(AMS 47%, ANZ 66%) which is close to parity (risks balanced against
benefits). Atlas‐based segmentation had significant variance in value
ratings (INTL 58%, AMS 28%, ANZ 83%).
4 | DISCUSSION
This practice pattern data provides useful insights into the interna-
tional status of rigid and deformable image registration implementa-
tion from 2008 to 2018. Historical evidence of the first uses of all
TAB L E 7 Data on image registration quality assurance methods and
metrics (QL denotes qualitative, QT denotes quantitative).
% divide per region
Americas ANZ
RO Phys RT Dos RO Phys RT
QL Anatomical landmarks
visualized
50 63 38 75 67 67 83
Anatomical landmarks
with screenshots
13 25 0 13 17 42 33
Anatomical landmarks
with grid/ruler
25 38 13 25 25 50 50
Comparison with
contours
50 50 25 50 33 67 67
Subjective
considerations
63 75 25 50 75 33 58
QT Target registration
error (TRE)
13 13 0 13 17 17 17
Mean distance to
agreement (MDA)
0 13 0 13 8 33 17
Dice similarity
coefficient (DSC)
0 13 0 13 0 33 8
Jacobian 0 13 0 13 8 8 8
Consistency
(transitivity)
0 25 0 13 0 17 0
TAB L E 8 International data (AMS and ANZ extended survey) with percentage (%) of respondents having datasets of a particular category (by
image modality, and subcategories from digital, physical, or clinical dataset types); *note that validation clinical datasets did not specify whether
it was directed toward RIR or DIR validation.
Digital datasets Physical datasets
Clinical datasets* (Rigid and/or
Deformable)
Rigid Deformable Rigid Deformable Retrospective Prospective
CT 30 40 60 15 60 25
MR 20 15 35 5 40 20
PET 20 15 20 0 35 20
CBCT 20 15 45 5 55 30
US 5 5 15 0 20 10
4DCT 5 10 30 10 35 20
4DCBCT 0 5 30 10 30 20
YUEN ET AL. | 9
DIR is presented along with the current and planned future adoption
rates (Fig. 3). Batumalai et al. sampled 33 out of 46 ANZ centers to
obtain a rate of 22% for DIR‐based multi‐modality treatment plan-
ning in August–October of 2015,14 compared with our data (18 ANZ
centers) of 11% (2015) to 17% (2016). Kisling et al. reported an
international rate of 26% for DIR with composite doses in 2016,16
which matched our rate of international value from our International
data (INTL 26%, AMS 42%, Asia 33%, EU 0%, ANZ 11%). In 2018,
Kadoya et al.15 surveyed Japanese practice and characterized the
use of deformed images (56%) and dose accumulation (73%) which
was within 10% of International averages from this study (65% and
63% on DIR for MMTP and for deformed dose, respectively);





Upstream 1 Processes to ensure sufficient information in image
2 Processes to ensure Setup factors between images optimized
3 Processes to ensure patient factors between scans optimized
4 Processes to ensure image quality optimized
5 Processes for satisfactory orientation and data integrity
6 Processes to ensure correct image registered
7 Processes to validate incorporation of previous RT information
8 Processes for Implicit registration prescription (e.g., protocol defining what landmark to register to)
9 Processes to prepare explicit registration prescription (e.g., RO writing patient specific instructions on what landmark to
register to)
Registration 10 Processes for interpreting implicit/explicit registration prescription
11 Registration technique optimal (rigid)
12 Registration technique optimal (deformable)
13 Processes to ensure image quality optimized (e.g., artifacts)
14 Landmarks in image identified
15 Registration QA
16 Uncertainty/issues documented
17 Accuracy level documented and reported
Downstream 18 Registration results interpreted
19 Decision when whole scan or local regions aligned
20 Decision when usable with risk of deformation (additional PTV margin may be required as per TG 132)
21 Processes to calculate and apply margin policy
22 Process followed when image registration is usable for diagnosis only or not for clinical use
23 Process to ensure atlas‐based contours checked/edited/finalized
24 Process to process/validate deformed image and dose
25 Process to document registration QA and actions in hospital database
Management 26 Managing roles/responsibilities with allocating time from trained staff to known task times
27 Quality management of imaging equipment
28 Sufficient datasets, validation, and procedures in place
29 Coordination and integration with RO, RT, Physics, as well as various portfolios. Also with Nuclear Medicine, Radiology,
Medical Oncology, etc.
30 In‐house software engineering or use of advanced vendor functions
31 Project management: balancing quality, risk, and efficiency
32 Reactive systems: all technical and human issues, incidents and near misses are managed
TAB L E 10 Survey data on image registration quality assurance
mechanism.
Respondent responses (%) per continent Americas Asia EU ANZ
Formal QA check task in system 19 17 14 56
Registration instruction in protocol 15 33 14 61
Registration instruction prescribed by RO 19 33 14 28
[DIR] Qualitative or quantitative check
of DVF and deformed image
35 0 43 17
Registration QA form with achieved
accuracy level documented
15 0 14 28
Decision tree or equivalent 8 0 0 11
None of the above 35 50 43 6
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similarly, the Japanese use of DIR for segmentation (63%) and propa-
gation (53%) are in broad agreement with our international data of
47% for atlas‐based segmentation. In the United States, adoption of
IGRT started around 1999 and 10 yr passed until it became main-
stream in 200913; our data show international adoption of DIR also
started around 2009 with significant growth in a decade, in parallel
with the adoption of IGRT. The survey data suggest that most
respondents intended to implement DIR for dose and multi‐modality
treatment planning by 2020–2026.
Even when DIR is an option, RIR use is dominant for the brain and
pelvis, which could be considered sites where the overall advantages
of RIR outweigh DIR. For example, while RIR may be considered suffi-
cient for brain21 due to the relatively nondeformable nature of the
skull, DIR for the prostate involves multiple complexities such as low
contrast in soft‐tissues,21,22 bowel gas,23 potential biomechanical
models,5 sliding tissues,6 and multiple treatment modalities (e.g.,
brachytherapy). This correlated with the 2018 Japanese DIR survey
which named prostate as the site where DIR performs the worst.15
For the brain, RIR could be used in multiple ways such as for MMTP,
to account for previous dose, and ART. ART can be simple or com-
plex with either RIR or DIR,24 and recent survey data of ART (using
either RIR or DIR) in India correlates with this survey showing relative
preference for use in the head and neck (92%) and lung (52%).25 The
data indicate that the characteristics of image differences across
anatomical site can drive DIR use: for example, lower levels of uncer-
tainty in the brain indicated that RIR was considered most appropri-
ate; head and neck had the second lowest score of uncertainty which
was among anatomical sites where DIR was most prevalent in our
data. Clinical uptake may correlate to DIR performance as published
by multi‐institutional studies such as for head and neck,26,27 lung,28
thorax,27,29 and pelvis.27 However, survey results of DIR use over
anatomical region indicate that DIR algorithms4 were considered
TAB L E 11 Summary of DIR software available by software type and whether the survey captured the data directly (yes), indirectly (open
response), or not at all (no).
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inherently not robust enough for general validation30 and use.8 In sce-
narios where DIR is challenging (e.g., tissue appearance or disappear-
ance6,31 or large deformations6), accurate use requires appropriate
management of uncertainties.4
Data on the use of RIR with multi‐modality imaging show the rel-
ative dominance of CT‐based imaging with different CT scans (plan-
ning CT to diagnostic CT, or to CBCT), with decreasing use of MR
(CT‐MR or MR‐MR) and US (CT‐US or US‐US). The imaging data
used, particularly primary planning images for plan generation but
also diagnostic and treatment imaging, could be a major factor in
how centers utilized DIR. This survey data agrees with the Japanese
data in 201815 which found single modality DIR (CT‐CT) as the most
common DIR image modality pair. Lower DIR usage of CT‐CBCT
usage could correspond to additional complexities such as image
noise and streaking32,33 for contour propagation, or image trunca-
tion32,34 for synthetic CT generation35 which may creep into the
implementation of adaptive radiotherapy.24,36,37
Data indicate that more centers have independent DIR software
than RTPS‐based DIR software. Department requirements for DIR
software may depend on factors including imaging modalities, treat-
ment modalities, and required applications. In addition to financial
costs of software licenses, there may be time and resources required
for ensuring specialized staff and validation equipment can support
the safe operations and quality assurance of such functions. While
the exact numbers of DIR software types and licenses was not sur-
veyed, minimum and optimal levels of software would depend on
the department specific merits (and costs) of (a) independent DIR
software flexible for all image data, (b) treatment focused DIR RTPS
software, or (c) research or validation DIR software. As departments
plan the scope of DIR implementation (e.g., accuracy and uncertainty
balance of RIR vs DIR), strategic planning considerations of the pro-
duct life cycles of each available solution38 could be important.
This study provides data on awareness of the TG132 report
(INTL 82%) as well as insight into the lack of widespread adoption
of the IR request and report form (INTL 18%), which may highlight a
community preference against the generation, communication, and
management of formal documentation for IR patient‐specific QA.
Three different approaches of evaluating IR processes (process satis-
faction, staff involvement, key challenges) found that key concerns
were registration accuracy classification (satisfactory or not) with
appropriate follow‐up use. Staff factors for IR potentially increases
with iterative RIR and DIR (Fig. 5); the dominance of qualitative over
F I G . 6 . Evaluation of adoption of AAPM
Task Group 132 (TG132) recommendations
of the request and report form for each
continent, from (i) not intending to follow
recommendations for the request/report
form to (vi) all recommendations followed
for the request/report form.
F I G . 7 . Box plot of benefit to risk rating
of Americas (AMS, red). Australasian (ANZ,
blue), and International (INTL, black)
perceptions of the value of atlas‐based
segmentation, use of DIR for multi‐
modality treatment planning (MMTP), use
of DIR for accounting for previous
treatment (PrevTx), and adaptive
radiotherapy (ART); Benefit to risk rating
of 100% indicates that the benefits
outweigh the risks significantly.
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quantitative QA (Table 7); and substantial variations in staff roles
across institutions (Table 4). Formal multidisciplinary IR training pro-
grams (currently lacking, as per Table 5) based on case studies with
qualitative and quantitative metrics could improve the general per-
formance of departmental IR techniques.
While Physicists may not necessarily be routinely involved in RIR,
survey data suggest that they have the highest involvement in DIR of
all professions, which is in agreement with the findings of a recent DIR
survey in Japan.15 While Physicists may be only indirectly involved in
operations they are directly responsible for assessing the performance
the IR algorithms and techniques, and provide clinical guidance on
associated actions and tolerances. Radiation Oncologists are expected
to have a key role in identifying clinical aims of IR, specifying the regis-
tration accuracy required, and ensuring the safe and appropriate use
of registration.4,39 RTs and Dosimetrists are strongly involved in imag-
ing before IR, have a key role in RIR, and a growing role in DIR. Survey
data indicates that multidisciplinary peer review and audits would
facilitate the safe operations of DIR, particularly when trained staff
have responsibilities for managing DIR accuracy4,5,30 supported by
departmental safety, risk, and incident reporting processes.
Data on implementation criteria show that the priority is for a
quality system based on registration accuracy, which requires trade‐
offs in documentation or management of uncertainties (AMS priority)
with a reduction in efficiency and rapid progress (ANZ priority). Due
to the inherent limitations of both RIR and DIR, management of IR
uncertainties may be required as routine practice,4 employing practi-
cal solutions such as automated generation of documentation. Data
on benefit to risk ratings, which can determine whether a technique
should be used in a department, showed that the largest benefit/risk
ratio was for accounting for previous dose (most worth implement-
ing), followed by MMTP, adaptive radiotherapy, and then atlas‐based
segmentation. This could be due to the increased complexity of
group‐wise registration with adaptive radiotherapy (up to a registra-
tion per treatment image)24 compared to re‐irradiations, where regis-
tration could be pair‐wise.8 Variability in benefit to risk ratings
reflects conflicting positions of minimizing risks (safety) vs imple-
menting DIR to increase accuracy (benefits).40 This could be
addressed with practical risk‐based solutions that systematically
address risks9 or increase benefits, with clinical translation appropri-
ate when benefits outweigh risks.41
The survey captured the use of most common commercial DIR
software15; however, the open text responses listed eight additional
DIR software products that were not in the survey question. A more
complete list of all software found in the literature is provided
(Table 11). Other limitations of the survey were limited time for sur-
vey data collection as it was required for an associated workshop,
limited international representation, and practical limits on partici-
pant time spent filling in the survey. At the time of survey design,
the authors did not include deep learning (DL) applications as an
alternative to DIR algorithms; while there were more publications of
DL techniques than DIR in 2018,42 there was a lack of commercial
DL software. Commercial DL contours have demonstrated superior-
ity over atlas‐based segmentation in accuracy and efficiency43; while
there are increasing and promising trends in DL‐based IR, challenges
remain44 and commercially DL IR are currently unavailable.
There are various limitations to the survey, including limited
responses due to the large number of questions (29 standard and 81
extended). This reduces accuracy and introduces potential systematic
bias45 such as the potential underestimation of DIR adoption in EU
(7 standard and 1 extended response) due to the low response rate
or overestimation with centers not practicing DIR choosing not to
participate in the survey. The categorization of data by continent
limits the usefulness of data for a particular region. Despite various
limitations such as in question design or responses, the survey
results offer insights and data not available elsewhere.
Future work could include a focused survey on multidisciplinary
use of DIR carried out in cooperation with national or organizational
stakeholders. This could be linked to multi‐institutional scientific
study of DIR performance based on shared datasets where DIR cor-
rections range from being beneficial to contraindicated.31,46 While
promising research such as deformable physical phantoms47‐50 and
automated deformable vector field analysis51,52 offer technical solu-
tions, practical validation of registration4 may require a combination
of qualitative with quantitative approaches.4,6 Similarly, it may be
prudent to focus in parallel on optimizing the safe use of commer-
cially available solutions for achievable improvements now, as well
as development for increasingly complex registration techniques,
such as predictive models of dose accumulation, online replanning,
and functional guidance.24
5 | CONCLUSION
An international survey was performed of radiotherapy departments
in the Americas, Asia, Europe, and Australia/New Zealand. Practice
pattern data on DIR software and RIR/DIR utilization for a range of
use cases and anatomical sites were obtained. This provides valuable
insight into implementation patterns of IR, enabling the development
of a coherent strategy for clinical adoption. Practice pattern data
from this survey could be used to develop institutional or regional
best practice guidelines for the safe and effective use of IR in radio-
therapy.
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